Probiotic Strain Composition for Safer 5-HTP Secretion Enhancement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for enhancing 5-hydroxytryptophan secretion by enterochromaffin cells, such as consuming tryptophan-rich foods or supplements, can cause side effects like nausea and serotonin syndrome, necessitating a safer and more effective approach.
Innovation Solution
Utilizing the Bifidobacterium animalis subsp. lactis BB-115 strain, optionally combined with Lactobacillus rhamnosus MP108 and Bifidobacterium longum subsp. infantis BLI-02 strains, to enhance 5-hydroxytryptophan secretion by enterochromaffin cells, thereby increasing serotonin precursor levels in the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If 5-hydroxytryptophan supplements are taken to increase serotonin levels, then serotonin concentration is improved, but side effects such as nausea, diarrhea, and serotonin syndrome occur
Solution Approach 1:
The patent uses probiotic bacteria (Lactobacillus helveticus and Bifidobacterium longum) as intermediary agents to stimulate enterochromaffin cells to produce 5-HTP endogenously, rather than directly administering 5-HTP supplements. This intermediary approach activates the body's own production mechanism, avoiding the side effects associated with direct supplementation while still achieving increased serotonin levels.
Solution Approach 2:
The invention enables the body's enterochromaffin cells to self-produce 5-hydroxytryptophan through stimulation by probiotic bacteria. Instead of relying on external supplementation, the body's natural cellular mechanisms are activated to generate the necessary compounds, creating a self-regulating system that avoids the harmful effects of exogenous 5-HTP intake.
2Quantity of substance
If tryptophan-rich foods are consumed to increase serotonin levels, then serotonin concentration is improved, but the intake amount required is large and may cause gastrointestinal discomfort
Solution Approach 1:
Rather than requiring large quantities of tryptophan-rich foods, the patent uses probiotic bacteria as intermediaries that efficiently convert available tryptophan into 5-HTP through stimulation of enterochromaffin cells. This intermediary mechanism amplifies the effectiveness of dietary tryptophan, achieving serotonin enhancement without the burden of consuming large food quantities.
Solution Approach 2:
The invention changes the metabolic parameter efficiency by introducing probiotic bacteria that enhance the conversion rate of tryptophan to 5-HTP. This parameter change in metabolic efficiency means that smaller amounts of dietary tryptophan can be effectively converted into sufficient 5-HTP levels, eliminating the need for large food intake.
3Quantity of substance
If high doses of 5-hydroxytryptophan are administered to ensure sufficient serotonin production, then serotonin concentration is improved, but the risk of serotonin syndrome increases
Solution Approach 1:
The body's enterochromaffin cells self-regulate 5-HTP production in response to probiotic stimulation, creating a controlled endogenous synthesis system. This self-service mechanism naturally limits production to physiological needs, preventing the dangerous accumulation that occurs with high-dose supplementation and eliminating the risk of serotonin syndrome.
Solution Approach 2:
The probiotic-mediated stimulation of enterochromaffin cells creates a feedback-controlled system where 5-HTP production responds dynamically to the body's actual needs. The probiotics continuously stimulate cell activity based on serotonin levels, creating a self-regulating feedback loop that prevents excessive 5-HTP accumulation and ensures safe, appropriate dosing without the risks associated with fixed high-dose regimens.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The BB-115 strain effectively enhances 5-hydroxytryptophan secretion, with synergistic effects when combined with MP108 and BLI-02 strains, addressing emotional and mental health issues like insomnia, depression, and anxiety without causing side effects.
Implementation Method 1
a Bifidobacterium animalis subsp. lactis BB-115 strain exhibits superior activity in enhancing the secretion of 5-hydroxytryptophan by enterochromaffin cells
Data Source
AI summary
A method for enhancing 5-hydroxytryptophan secretion by enterochromaffin cells is disclosed, and the method comprises: administering a composition to a subject in need thereof, the composition comprising: a Bifidobacterium animalis subsp. lactis BB-115 strain. Herein, another method for enhancing 5-hydroxytryptophan secretion by enterochromaffin cells through administering a composition to a subject in need thereof, the composition comprising: a Bifidobacterium animalis subsp. lactis BB-115 strain, a Lactobacillus rhamnosus MP108 strain, and a Bifidobacterium longum subsp. infantis BLI-02 strain.